AI-focused biotech Deepcell is partnering with Nvidia to expand its use of generative AI in cell biology, the company announced Monday afternoon. The partnership — unveiled at the JP Morgan Healthcare ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with ...
OXFORD, England--(BUSINESS WIRE)--British techbio innovator Etcembly is coming out of stealth mode, kickstarting the next generation of immunotherapies with a pipeline of best-in-class T cell receptor ...
Similar to generative AI models that create pictures based on a photo, or a textual description of a motive, in the style of different artists, the VirtualMultiplexer produces virtual colorations for ...
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Precision oncology in non–small ...
Initial clinical data from the ongoing Phase 1 study of ACR-2316, a potential first- and best-in-class WEE1/PKMYT1 inhibitor, including safety data, dosing regimen, and early clinical activity across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback